Amorolfine 5% Glenmark 50 mg Nail lacquer
PDF Leaflet Revision Date: 15 October 2024
Clinical Summary
Quick overview from the medicine insert
Indication
Onychomycoses caused by dermatophytes, yeasts, and moulds.
Dosage (summary)
Apply once or twice weekly to affected nails.
Special Populations
- Children
Pregnancy & Breastfeeding
Not recommended during pregnancy and lactation due to limited experience.
Key Drug Interactions
- Avoid use with nail varnish or artificial nails during treatment.
Contraindications
- Hypersensitivity to amorolfine or excipients
- Pregnancy
- Lactation
- Children
Common side effects
- Nail discoloration
- Broken nails
- Brittle nails
Counselling Points
- File down affected nails before application.
- Clean nails with alcohol swab before each application.
- Do not reuse nail files on healthy nails.
Serious warnings
- Avoid contact with skin around nails, eyes, ears, and mucous membranes.
Important Disclaimer
The Amorolfine 5% Glenmark 50 mg Nail lacquer professional information leaflet below is the property of Glenmark Pharmaceuticals South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
